{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:09:31Z","timestamp":1763388571412,"version":"3.30.1"},"reference-count":19,"publisher":"Medknow","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1745-7262.2008.00422.x","type":"journal-article","created":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T17:19:39Z","timestamp":1219079979000},"page":"791-798","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial"],"prefix":"10.4103","volume":"10","author":[{"given":"Jae-Seung","family":"Paick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Ki","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Young","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae-Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwanjin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyonggi","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Cheol","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1743-6109.2007.00602.x","article-title":"Prevalence and correlates of erectile dysfunction (ED) and treatment seeking for ED in Asian men: the Asian Men's Attitudes to Life Events and Sexuality (MALES) study","volume":"4","author":"Tan","year":"2007","journal-title":"J Sex Med"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0302-2838(03)00215-X","article-title":"Male erectile dysfunction and health-related quality of life.","volume":"44","author":"Sanchez-Cruz","year":"2003","journal-title":"Eur Urol"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.ijir.3900269","article-title":"On life satisfaction in male erectile dysfunction.","volume":"9","author":"Fugl-Meyer","year":"1997","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2006.07.020","article-title":"Phosphodiesterase type 5 inhibitors: the day after.","volume":"51","author":"Hatzimouratidis","year":"2007","journal-title":"Eur Urol"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1745-7262.2006.00213.x","article-title":"Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.","volume":"8","author":"Yip","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.eururo.2006.09.027","article-title":"Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).","volume":"51","author":"Martin-Morales","year":"2007","journal-title":"Eur Urol"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.ju.0000071478.69480.fd","article-title":"Clinical efficacy of sildenafil citrate and predictors of long-term response.","volume":"170","author":"Gonzalgo","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB8","first-page":"117","article-title":"Reasons for discontinuation of sildenafil citrate after successful restoration of erectile function.","volume":"6","author":"Son","year":"2004","journal-title":"Asian J Androl"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.ijir.3900883","article-title":"Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users.","volume":"14","author":"Souverein","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/jlcr.1116","article-title":"Synthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1 -ylsulfonyl]-2-n-propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C]pyrimidin -4-one 2HC1 (14C-SK3530.2HC1).","volume":"49","author":"Shin","year":"2006","journal-title":"J Label Compd Radiopharm"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/rcm.2943","article-title":"Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-l-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo [3,2-d]-pyrimidin-4-one (SK3530) in rats.","volume":"21","author":"Lee","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1464-410X.2007.06916.x","article-title":"Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men na?ve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.","volume":"100","author":"Eardley","year":"2007","journal-title":"BJU Int"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.ijir.3900944","article-title":"A double-blind, randomised- placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea","volume":"15","author":"Choi","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.ju.0000063377.12281.57","article-title":"Deciphering erectile dysfunction drug trials.","volume":"170","author":"Mulhall","year":"2003","journal-title":"J Urol"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J Androl"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1464-410X.2004.05049.x","article-title":"Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.","volume":"94","author":"Eardley","year":"2004","journal-title":"BJU Int"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijir.3901522","article-title":"The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy.","volume":"19","author":"Mehrotra","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB18","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1745-7262.2007.00319.x","article-title":"Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.","volume":"9","author":"Ahn","year":"2007","journal-title":"Asian J Androl"},{"key":"10.1111\/j.1745-7262.2008.00422.x-BIB19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. A critical review of available methods.","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T10:50:13Z","timestamp":1709203813000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.asiaandro.com\/Abstract.asp?doi=10.1111\/j.1745-7262.2008.00422.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1745-7262.2008.00422.x","relation":{},"ISSN":["1008-682X","1745-7262"],"issn-type":[{"type":"print","value":"1008-682X"},{"type":"electronic","value":"1745-7262"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}